Mesenchymal Stromal Cells’ Therapy for Polyglutamine Disorders: Where Do We Stand and Where Should We Go?

Overview of attention for article published in Frontiers in Cellular Neuroscience, October 2020

Altmetric Badge

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 26 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 75,707 followers.

Review: Mesenchymal Stromal Cells' Therapy for Polyglutamine Disorders: Where Do We Stand and Where Should We Go? https://t.co/DZIVI0bEpe - polyQ

04 Nov 2020

Reply Repost Favourite

RT @FrontNeurosci: New Research: Mesenchymal Stromal Cells’ Therapy for Polyglutamine Disorders: Where Do We Stand and Where Should We Go?:…

19 Oct 2020

Reply Repost Favourite

New Research: Mesenchymal Stromal Cells’ Therapy for Polyglutamine Disorders: Where Do We Stand and Where Should We Go?: Polyglutamine (polyQ) diseases are a group of inherited neurodegenerative disorders caused by the expansion of the… https://t.co/SqsBWr

19 Oct 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.